Moderately intense physical activity key to cutting dementia risk: study
By
Alicia Lasek
Feb 01, 2023
For each additional 31 minutes per day of moderate-to-vigorous activity, there is 21% lower risk of dementia for senior women, researchers report.
New data: With no booster, nursing home residents face 30 percent higher COVID risk
By
Alicia Lasek
Jan 29, 2023
Nursing home residents who have received the COVID-19 bivalent booster shot are 30% to 50% less likely to become infected with SARS-CoV-2 than their fellow residents who haven’t gotten boosted, the...
Study: Shift to home COVID tests leads to vast undercount of cases
By
Alicia Lasek
Jan 30, 2023
Home testing may have begun to interfere with the ability to accurately track COVID-19 case counts and positivity rates, investigators report.
VA’s narrative medicine program improves senior patient care, docs’ study finds
By
Alicia Lasek
Jan 25, 2023
Physicians said that the practice of narrative medicine changed how they framed patient decisions and helped them to guide seniors toward appropriate care.
Study: Falls rate nearly 50% for U.S. seniors with dementia; 3 factors raise risk
By
Alicia Lasek
Jan 13, 2023
Nearly half of American seniors with dementia had one or more falls in the preceding year, according to a new analysis of 2016 data. Risk factors differed between seniors with and without dementia, investigators...
Most ‘long COVID’ symptoms resolve within a year, national study finds
By
Alicia Lasek
Jan 13, 2023
Patients who recover from mild COVID-19 are at risk for health issues tied to long COVID. Most of these problems resolve with a year — at least for those aged 60 and younger, a new study has found.
Tap water is not sterile for use in medical devices; many people unaware, CDC finds
Jan 13, 2023
Large numbers of Americans mistakenly believe that tap water is safe for use in home medical devices such as CPAP machines, a CDC survey reveals.
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.
Peer messaging tool tackles workplace behavior, shows success in nurse study
By
Alicia Lasek
Jan 06, 2023
The CORS tool allows behavior to be anonymously reported and addressed by a trained peer, without involving nursing leadership or human resources unless necessary.
U.S. releases Tamiflu doses from national stockpile as demand surges
By
Alicia Lasek
Dec 22, 2022
The U.S. has opened more access to an influenza antiviral to help clinicians cope with rising demand during the worst flu season in a decade